Bnp Paribas Asset Management Holding S.A. Procept Bio Robotics Corp Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 784,213 shares of PRCT stock, worth $30.3 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
784,213
Previous 343,511
128.29%
Holding current value
$30.3 Million
Previous $20 Million
125.72%
% of portfolio
0.11%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding PRCT
# of Institutions
292Shares Held
44MCall Options Held
248KPut Options Held
90.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$203 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$135 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$83.3 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$59 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.32MShares$51 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.72B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...